Abiraterone Acetate | List of High Impact Articles | PPts | Journals | Videos

Journal of Prostate Cancer
Open Access

Abiraterone Acetate

Search results for
Abiraterone Acetate

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abiraterone Acetate

Abiraterone acetate is a type of hormone therapy, classified as an “adrenal inhibitor". It is indicated for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel.

Adverse effect: Hypertension: Abiraterone may cause an increase in blood pressure, Urinary tract infection: Cloudy or smelly urine, pain or discomfort when passing urine, Diarrhea : Drink plenty of fluids if you have diarrhea at least 2 litres (about 3 pints) a day.

Related Journals of Abiraterone Acetate

Journal of Prostate Cancer, Journal of Cancer Science & Therapy, The Lancet Oncology, Prostate Cancer Learning Hub, journal of clinical oncology, European society for medical oncology

Abiraterone Acetate

Speaker PPTs

Conference Proceedings